Generate Biomedicines, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 14.46 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.86B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.
Details
| Name | Generate Biomedicines, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 312 |
| Founded | 2018 |
| Ipo Date | 2026-02-27 |
| Ceo | Michael Nally |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US3709201004 |
| Cusip | 370920100 |
| Cik | 2100782 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Michael T. Nally M.B.A. | Chief Executive Officer and Director |
| Dr. Noubar B. Afeyan Ph.D. | Co-founder and Independent Chair of the Board |
| Dr. Jason E. Silvers J.D., M.D. | President and Chief Financial Officer |
| Dr. Gevorg Grigoryan Ph.D. | Co-Founder and Chief Technology Officer |
| Molly Gibson Ph.D. | Co-Founder |
| Dr. Aarif Khakoo M.B.A., M.D. | Chief Scientific Officer |
| Sean B. W. Martin J.D. | Secretary, Chief Legal Officer and General Counsel |
| Beth Grous | Chief People Officer |
| Dr. Daria Hazuda Ph.D. | Senior Vice President of Discovery Strategy |
| Sahm Nasseri M.B.A. | Senior Vice President of Business Development and Strategy |
Contact
| Address | 101 South Street, Suite 900, Somerville, Massachusetts 02143, United States |
| Phone | (888) 469-0055 |
| Website | https://generatebiomedicines.com |